Search

everythinglearnresearchcommunity

for

Search:↓

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

UV rays can cause a type of hair loss known as telogen alopecia.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Sunlight worsens hair loss; protect scalp.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

Alitretinoin may cause irreversible hair curling as a side effect.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

Careful planning and technique in upper facial rejuvenation can minimize risks like hair loss, nerve damage, and scarring.